Registration Decision RD2020-16, Broflanilide, Cimegra, Teraxxa and Teraxxa F4

This decision is consistent with the Proposed Registration Decision, PRD2020-06, Broflanilide, Cimegra, Teraxxa and Teraxxa F4, which contains a detailed evaluation of the information submitted in support of this registration.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-03-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data